XORTX Therapeutics Inc. (XRTX) stock
XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.06+0.00 (0.00%)
Close on Nov 18, 2026Market cap $116.17KP/E –Yield –
XORTX Therapeutics net income
Net income is the profit left for shareholders after every expense, interest and tax.
No net income figures for XORTX Therapeutics
XORTX Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?